INS and type 2 diabetes mellitus: Yet, in 2010, a major randomized control trial of 2368 patients found that those with stable ischemic heart disease and T2DM had a significant reduction in MI only with IS regimens (but not insulin-preserving regimens) post-CABG, with a decreased but non-significant reduction post-PCI [233].